Panzara Michael A. 4
4 · Wave Life Sciences Ltd. · Filed Feb 21, 2019
Insider Transaction Report
Form 4
Panzara Michael A.
Franchise Lead, Neurology
Transactions
- Sale
Ordinary Shares
2019-02-19$36.84/sh−1,837$67,674→ 37,388 total
Footnotes (2)
- [F1]On February 19, 2019, the reporting person sold 1,837 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 15, 2019. These sales were made pursuant to a 10b5-1 Trading Plan.
- [F2]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $36.83 to $37.4713 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.